Blood vessel inhibitor shows promise against metastatic thyroid cancer
Thursday, July 3, 2008 - 10:35
in Health & Medicine
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Read the whole article on Physorg
More from Physorg
Related
- Blood vessel inhibitor shows promise against metastatic thyroid cancerThu, 3 Jul 2008, 11:36:19 EDT
- New mechanism explains how the body prevents formation of blood vesselsWed, 11 Nov 2009, 10:40:12 EST
- Angiogenesis linked to poor survival in patients with rare type of ovarian cancerThu, 5 Feb 2009, 11:52:21 EST
- Drug that targets vasculature growth attacks aggressive thyroid cancerFri, 15 May 2009, 9:16:35 EDT
- Drug inhibits neuroblastoma blood supply in pre-clinical testsFri, 24 Apr 2009, 12:03:53 EDT